Group
About Us
Hemolab Pharma provides essential hospital and specialty medications, focusing on injectable presentations.
Established in 1996 to meet the needs of nephrologists, Hemolab Pharma specializes in the production of hemodialysis concentrates and the distribution of vital medications.
Hemolab Pharma is a partner of international actors, notably French and Spanish, and continues its development by investing in medications with significant medical benefits.
Mission
We save lives by providing hospitals with essential and vital medications. We are crucial partners for hospitals in ensuring access to fundamental healthcare.
Vision
To be an essential, competent, and recognized local and regional player.
Values
ENTREPRENEURSHIP
Innovate with agility, commitment, and ownership
PERSEVERANCE
Relentlessly pursue our efforts
HUMILITY
Achieve collectively with merit and without pretension
INTEGRITY
Operate with clarity, transparency and integrity
RESPECT
Treat everyone with professionalism and respect
TEAM
Be united, proactive, and reliable
History
Hemolab is a pioneer in hemodialysis in Morocco established in 1994. It diversified its activities in 1995 with Hemolab Pharma, becoming the first manufacturer of hemodialysis concentrate in the country. The acquisition of SPMCP in 2000 strengthened its position in the medical devices segment. Since then, the group has expanded to cover anaesthesia, resuscitation, oncology, biopharmaceuticals, diagnostics and water.
Therapeutic Areas
Anaesthesia Reanimation
Injectable medications for patient management in the operating room and post-operatively. Pioneer in pre-filled syringes.
Nephrology
Hemolab Pharma is the first manufacturer of hemodialysis concentrate in Morocco. We provide liquid concentrate in containers, in 1000-litre tanks (acid), and in cartridges (bicarbonate). We also install our centralized distribution system for acid concentrate.
We also offer a complete range of medications for the management of hemodialysis patients.
Oncology
A range of medications with significant medical service rendered in oncology and haematology.
Neurology
For the management of Parkinson's disease and patients suffering from chronic spasticity.
News
Partnership
Our partnerships have lasted for several decades, characterized by success resulting from strong synergies in terms of portfolio and channel.
These collaborations are meticulously studied, pre-planned, and executed methodically.
Our partners
